Enantioselective Epoxidation of α,β-Enones by Electrophilic Activation
FULL PAPER
maining starting material and the α,β-epoxy ketone were isolated
in this sequence. (R)-BINOL was recovered almost quantitatively
as the last fraction.
73% ee. [α]2D6 = –7.8 (c = 0.94, CH2Cl2). Literature value for the
other enantiomer (2R,3S): [α]2D6 = +13.8 (c = 1.4, CH2Cl2, ee =
91%).[9b]
B: (R)-BINOL (57 mg, 0.2 mmol) was dissolved in Et2O (4 mL) in
a 50-mL Schlenk flask equipped with a magnetic stirring bar under
an inert atmosphere. After cooling to 0 °C in an ice-bath, ZnEt2
(0.18 mL, 0.2 mmol, 1.1 m solution in toluene) was added whilst
stirring. After 3 h the complete precipitation of an amorphous
white solid was observed and α,β-unsaturated ketone (1 mmol) and
CMHP (0.22 mL, 1.2 mmol, 80% solution in cumene) were added;
stirring of the reaction mixture at room temperature was main-
tained for the indicated time. The reaction was quenched with aq.
sat. NaHSO3 and extracted with EtOAc. The organic layer was
washed with aq. Na2CO3 and brine. The combined organic layers
were dried with MgSO4, and the solvent was evaporated in vacuo.
The residue was purified by column chromatography. CH2Cl2 was
used as eluent in all cases and remaining starting material and the
α,β-epoxy ketone were isolated in this sequence. (R)-BINOL was
recovered almost quantitatively as the last fraction.
(E)-Phenyl-(3-propyloxiran-2-yl)methanone:[9b]
1H
NMR
(300 MHz, CDCl3): δ = 1.01 (t, J = 7.4 Hz, 3 H, CH3), 1.48–1.83
(m, 4 H, CH2CH2), 3.15 (m, 1 H, Hβ), 4.03 (d, J = 2 Hz, 1 H, Hα),
7.47–7.65 (m, 3 H), 8.01 (m, 2 H) ppm. GCMS: m/z = 189 [M+
–
H], 147 [M+ – C3H7], 131 [M+ – C3H7O], 105 [C7H5O+]. HPLC
(Chiracel OD, n-hexane/2-propanol, 90:10, 0.5 mLmin–1): tR
=
11.88 min (2S,3R-enantiomer, major), tR = 12.60 min (2R,3S-en-
antiomer, minor), 64% ee. [α]2D6 = –1.3 (c = 0.9, CH2Cl2). Literature
value for the other enantiomer (2R,3S): [α]2D6 = +1.7 (c = 1.0,
CH2Cl2, ee = 76%).[10]
(E)-(3-Isopropyloxiran-2-yl)phenylmethanone:[9b]
1H
NMR
(300 MHz, CDCl3): δ = 1.07 (d, J = 6.7 Hz, 3 H, CH3), 1.10 (d, J
= 6.7 Hz, 3 H, CH3), 1.79 (m, 1 H, CH), 2.96 (dd, J = 6.7 Hz,
2.0 Hz, 1 H, Hβ), 4.07 (d, J = 2.0 Hz, 1 H, Hα), 7.47–7.64 (m, 3
H), 8.02 (m, 2 H) ppm. GCMS: m/z = 189 [M+ – H], 174 [M+ – O],
147 [M+ – C3H7], 105 [C7H5O+]. HPLC (Chiracel OD, n-hexane/2-
propanol, 90:10, 0.5 mLmin–1): tR = 11.08 min (2S,3R-enantiomer,
major), tR = 12.18 min (2R,3S-enantiomer, minor), 68% ee.
[α]2D6 = –21.9 (c = 1.2, CH2Cl2). Literature value for the other
enantiomer (2R,3S): [α]2D6 = +32 (c = 1.3, CH2Cl2, ee = 92%).[10]
(E)-Phenyl-(3-phenyloxiran-2-yl)methanone:[24]
1H
NMR
(300 MHz, C6D6): δ = 4.04 (d, J = 1.8 Hz, 1 H, Hβ), 4.06 (d, J =
1.8 Hz,1 H, Hα), 6.97–7.15 (m, 8 H), 7.81 (m, 2 H) ppm. GCMS:
m/z = 224 [M+], 207 [M+ – OH], 105 [C7H5O+]. HPLC (Chiracel
OD, n-hexane/2-propanol, 95:5, 0.7 mLmin–1): tR = 15.17 min
(2S,3R-enantiomer, major), tR = 16.35 min (2R,3S-enantiomer,
minor), 90% ee. [α]2D6 = +207.7 (c = 0.78, CH2Cl2). Literature value
for the other enantiomer (2R,3S): [α]2D6 = –130.0 (c = 1.1, CH2Cl2,
ee = 61%).[9b]
(E)-(3-tert-Butyloxiran-2-yl)phenylmethanone:[29]
1H
NMR
(300 MHz, CDCl3): δ = 1.02 [s, 9 H, C(CH3)3], 2.94 (d, J = 2.2 Hz,
1 H, Hβ), 4.09 (d, J = 2.2 Hz, 1 H, Hα), 7.45–7.60 (m, 3 H), 7.97–
8.01 (m, 2 H) ppm. GCMS: m/z = 204 [M+], 189 [M+ – CH3], 173
[M+ – CH3O], 147 [M+ – C4H9], 105 [C7H5O+]. HPLC (Chiracel
OD, n-hexane/2-propanol, 90:10, 0.4 mLmin–1): tR = 12.38 min
(2S,3R-enantiomer, major), tR = 14.23 min (2R,3S-enantiomer,
minor), 96% ee. [α]2D6 = –18.0 (c = 1.3, CHCl3). Literature value
for the other enantiomer (2R,3S): [α]2D6 = +14 (c = 0.36, CH2Cl2,
ee = 64%).[10]
(E)-β-Benzoyloxystyrene:[30] 1H NMR (300 MHz, CDCl3): δ = 6.51
(d, J = 12.76 Hz, 1 H, Hβ), 7.17 (m, 1 H), 7.26 (m, 2 H), 7.32 (m,
2 H), 7.41 (m, 2 H), 7.53 (m, 1 H), 8.01 (d, J = 12.76 Hz, 1 H, Hα),
8.07 (m, 2 H) ppm. GCMS: m/z = 224 [M+], 105 [C7H5O+].
(E)-[3-(p-Bromophenyl)oxiran-2-yl]phenylmethanone:[25] 1H NMR
(300 MHz, CDCl3): δ = 3.95 (d, J = 1.8 Hz, 1 H, Hβ), 4.15 (d, J =
1.8 Hz, 1 H, Hα), 7.14 (d, J = 8.5 Hz, 2 H), 7.37–7.55 (m, 5 H),
7.90 (d, J = 7 Hz, 2 H) ppm. GCMS: m/z = 302 [C15H1179BrO2+],
+
286 [C15H1179BrO2 – O], 105 [C7H5O+]. HPLC (Chiracel OD-H,
n-hexane/2-propanol, 90:10, 0.4 mLmin–1): tR = 27.08 min (2S,3R-
enantiomer, major), tR = 29.12 min (2R,3S-enantiomer, minor),
90% ee. [α]2D6 = +137.2 (c = 1.22, CH2Cl2).
(E)-[3-(p-Nitrophenyl)oxiran-2-yl]phenylmethanone:[26] 1H NMR
(300 MHz, CDCl3): δ = 4.11 (d, J = 1.8 Hz, 1 H, Hβ), 4.17 (d, J =
1.8 Hz, 1 H, Hα), 7.29 (d, J = 9 Hz, 1 H), 7.44 (t, J = 8 Hz, 4 H),
7.91 (d, J = 7 Hz, 2 H), 8.16 (d, J = 8.9 Hz, 2 H) ppm. GCMS:
m/z = 269 [M+], 165 [M+ – C7H5O+], 105 [C7H5O+]. HPLC (Chira-
Acknowledgments
cel OD-H, n-hexane/2-propanol, 75:25, 0.5 mLmin–1): tR
=
We thank the Fonds der Chemischen Industrie for a doctoral fel-
lowship (Ana Minatti) and for financial support.
31.38 min (2S,3R-enantiomer, major), tR = 34.37 min (2R,3S-en-
antiomer, minor), 76% ee. [α]2D6 = +156.8 (c = 0.98, CH2Cl2). Lit-
erature value for the other enantiomer (2R,3S): [α]2D5 = –274.0 (c =
2.0, CH2Cl2, ee = 99%).[27]
[1] a) L. Carde, D. H. Davies, S. M. Roberts, J. Chem. Soc., Perkin
Trans. 1 2000, 2455–2463; b) For a recent review, see: C. Lau-
ret, Tetrahedron: Asymmetry 2001, 12, 2359–2383.
(E)-(3-Methyloxiran-2-yl)phenylmethanone:[28] 1H NMR (300 MHz,
CDCl3): δ = 1.52 (d, J = 5.5 Hz, 3 H, CH3), 3.46 (dq, J = 5.5,
2 Hz, 1 H, Hβ), 3.96 (d, J = 2 Hz, 1 H, Hα), 7.31–7.75 (m, 3 H),
[2] E. Weitz, A. Scheffer, Ber. Dtsch. Chem. Ges. 1921, 54, 2327–
2344.
7.95–8.11 (m, 2 H) ppm. GCMS: m/z = 161 [M+ – H], 146 [M+
–
[3] For recent reviews, see: a) M. J. Porter, J. Skidmore, Chem.
Commun. 2000, 1215–1225; b) T. Nemoto, T. Ohshima, M. Shi-
basaki, J. Synth. Org. Chem. Jpn. 2002, 60, 94–105; c) For a
recent review on asymmetric epoxidation, see: Q. H. Xia, H. Q.
Ge, C. P. Ye, Z. M. Liu, K. X. Su, Chem. Rev. 2005, 105, 1603–
1662.
[4] a) S. Juliá, J. Masana, J. C. Vega, Angew. Chem. Int. Ed. Engl.
1980, 19, 929–931; b) S. Juliá, J. Guixer, J. Masana, J. Rocas,
S. Colonna, R. Annunziata, H. Molinari, J. Chem. Soc., Perkin
Trans. 1 1982, 1317–1324.
[5] For recent reviews, see: a) S. Ebrahim, M. Wills, Tetrahedron:
Asymmetry 1997, 8, 3163–3173; b) L. Pu, Tetrahedron: Asym-
metry 1998, 9, 1457–1477; c) C. Lauret, S. M. Roberts, Aldrichi-
mica Acta 2002, 35, 47–51; d) For recent developments, see: A.
Berkessel, N. Gasch, K. Glaubitz, C. Koch, Org. Lett. 2001, 3,
O], 105 [C7H5O+]. HPLC (Chiracel OD, n-hexane/2-propanol,
90:10, 0.4 mLmin–1): tR = 17.47 min (2S,3R-enantiomer, major), tR
= 18.58 min (2R,3S-enantiomer, minor), 68% ee. [α]2D6 = +9.5 (c =
0.78, CHCl3). Literature value for the other enantiomer (2R,3S):
[α]2D5 = –10.0 (c = 0.6, CHCl3, ee = 63%).[6]
(E)-(3-Ethyloxiran-2-yl)phenylmethanone:[9b] 1H NMR (300 MHz,
CDCl3): δ = 1.09 (t, J = 7.4 Hz, 3 H. CH3), 1.69–1.90 (m, 2 H,
CH2), 3.15 (m, 1 H, Hβ), 4.04 (d, J = 2.0 Hz, 1 H, Hα), 7.47–7.65
(m, 3 H), 8.02 (m, 2 H) ppm. GCMS: m/z = 176 [M+], 147 [M+
–
C2H5], 131 [M+ – C2H5O], 105 [C7H5O+]. HPLC (Chiracel OD, n-
hexane/2-propanol, 90:10, 0.5 mLmin–1): tR = 12.47 min (2S,3R-
enantiomer, major), tR = 13.37 min (2R,3S-enantiomer, minor),
Eur. J. Org. Chem. 2006, 268–276
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
275